Investor Relations June 1, 2023 Nexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin’s tACS Devices in the Asia Pacific Region Read More
Investor Relations March 27, 2023 Nexalin Technology Provides 2022 Year-End Business Update Read More
Investor Relations January 24, 2023 Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory Read More
Investor Relations November 14, 2022 Nexalin Technology Announces Publication of a White Paper Validating its tACS Device for the Treatment of Generalized Anxiety Disorder Read More
Investor Relations September 20, 2022 Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial Public Offering Read More
